Graft rejection after unrelated donor hematopoietic stera cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction

被引:98
作者
Fleischhauer, K
Locatelli, F
Zecca, M
Orofino, MG
Giardini, C
de Stefano, P
Pession, A
Iannone, AM
Carcassi, C
Zino, E
La Nasa, G
机构
[1] IRCCS, Policlin San Matteo, Immunohematol & Transfus Med Serv, HLA Tissue Typing Lab, I-27100 Pavia, Italy
[2] Ist Ricovero & Cura & Carattere Sci, San Raffaele Telethon Inst Gene Therapy, HLA Tissue Typing Lab, Immunohematol & Transfus Med Serv, Milan, Italy
[3] Univ Cagliari, Dept Biomed & Biotechnol Sci, Bone Marrow Transplantat Unit, I-09124 Cagliari, Italy
[4] Osped San Salvatore, Dept Hematol, Bone Marrow Transplantat Unit Muraglia, Pesaro, Italy
[5] Univ Bologna, Osped S Orsola Malpighi, Dept Pediat, Bologna, Italy
[6] Osped Binaghi, Bone Marrow Transplantat Unit, Cagliari, Italy
关键词
D O I
10.1182/blood-2005-08-3374
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The success of allogeneic hematopoietic stem cell transplantation (HSCT) from matched unrelated donors (UDs) for beta-thalassemia may be hampered by the occurrence of graft rejection. Here, we show that the rate of this complication can be reduced by selecting 5-loci HLA-matched donors without nonpermissive mismatches at HLA-DPB1, defined according to an algorithm previously described and based on principles of central T-cell tolerance. Seventy-two consecutive patients and their UDs, prospectively selected for matching at the allelic level for HILA-A, -B, -C, -DRB, and -DQB1 loci, were enrolled in the analysis. These pairs were either DPB1 matched/permissively mismatched (n = 45, control group) or had at least one nonpermissive DPB1 mismatch in the host-versus-graft (HvG; n 17) or in the graft-versus-host (GvH; n 10) direction. In multivariate analysis, the risk of rejection was significantly increased in the group with HvG disparity (FIR = 7.42; 95% CI = 1.29-42.68; P = .02) as compared to the control group. A lower, statistically significant, probability of thalassemia-free survival was found in patients belonging to the HvG group as compared to controls (FIR = 5.15; 95% CI = 1.58-16.82; P = .01). These data suggest that in patients with thalassemia, the incidence of graft failure after HSCT may be reduced by appropriate selection of UDs, with such selection taking into account the functional rules of immunogenetics.
引用
收藏
页码:2984 / 2992
页数:9
相关论文
共 34 条
  • [1] Selection and fine-tuning of the autoimmune T-CELL repertoire
    Anderton, SM
    Wraith, DC
    [J]. NATURE REVIEWS IMMUNOLOGY, 2002, 2 (07) : 487 - 498
  • [2] Anti-HLA class II antibodies in kidney retransplant patients
    Arnold, ML
    Pei, R
    Spriewald, B
    Wassmuth, R
    [J]. TISSUE ANTIGENS, 2005, 65 (04): : 370 - 378
  • [3] Byar DP., 1988, CANC CLIN TRIALS MET, P423
  • [4] COX DR, 1972, J R STAT SOC B, V34, P187
  • [5] Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain
    Ferrara, GB
    Bacigalupo, A
    Lamparelli, T
    Lanino, E
    Delfino, L
    Morabito, A
    Parodi, AM
    Pera, C
    Pozzi, S
    Sormani, MP
    Bruzzi, P
    Bordo, D
    Bolognesi, M
    Bandini, G
    Bontadini, A
    Barbanti, M
    Frumento, G
    [J]. BLOOD, 2001, 98 (10) : 3150 - 3155
  • [6] Peripheral blood stem cell allograft rejection mediated by CD4+ T lymphocytes recognizing a single mismatch at HLA-DPβ1*0901
    Fleischhauer, K
    Zino, E
    Mazzi, B
    Sironi, E
    Servida, P
    Zappone, E
    Benazzi, E
    Bordignon, C
    [J]. BLOOD, 2001, 98 (04) : 1122 - 1126
  • [7] Bone marrow transplantation for beta-thalassemia
    Giardini, C
    Lucarelli, G
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (05) : 1059 - +
  • [8] Acute graft-vs-host disease: Pathobiology and management
    Goker, H
    Haznedaroglu, IC
    Chao, NJ
    [J]. EXPERIMENTAL HEMATOLOGY, 2001, 29 (03) : 259 - 277
  • [9] Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO
  • [10] 2-O